# Effectiveness and Cost-Effectiveness Evaluations of AI-Assisted Diagnostic Software (VeriSee) for Ophthalmic Disease Screening

> **NCT06843499** · NA · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Age-Related Macular Degeneration (AMD)
- Diabetic Retinopathy (DR)

## Interventions

- **OTHER:** The VeriSee AI-assisted diagnostic system
- **OTHER:** Data collection from the patient's clinical history

## Key facts

- **NCT ID:** NCT06843499
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-02
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-06-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06843499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06843499, "Effectiveness and Cost-Effectiveness Evaluations of AI-Assisted Diagnostic Software (VeriSee) for Ophthalmic Disease Screening". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06843499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*